Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: Possible interactions with dopamine receptors

Neuropharmacology

Volumn 44, Issue 6, 2003, Pages 717-727

  David, H N ^a   Abraini, J H ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Amphetamine; Dopamine; Glutamate; Locomotor activity; Metabotropic glutamate receptors

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINOPYRROLIDINE 2,4 DICARBOXYLATE; 4 CARBOXYPHENYLGLYCINE; ALPHA METHYL 4 PHOSPHONOPHENYLGLYCINE; AMPHETAMINE; DOPAMINE RECEPTOR; LIGAND; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG RECEPTOR BINDING; HABITUATION; LOCOMOTION; MALE; MOTOR ACTIVITY; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 0037402026     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00052-2     Document Type: Article

References (60)

1. Abraini J.H., Fechtali T., Rostain J.-C. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors. Neuroscience. 50:1992;395-402.
2. Abraini J.H., Tomei C., Rostain J.-C. Role of dopamine receptors in the occurrence of the behavioral motor disturbances in rats exposed to high pressure. Pharmacology, Biochemistry and Behavior. 39:1991;773-779.
3. Attarian S., Amalric M. Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induced dopamine-dependent locomotor activation in the rat. European Journal of Neuroscience. 9:1997;809-816.
4. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., Robinson T.E. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behavioral Brain Research. 103:1999;203-209.
5. Bouron A., Reuter H. The D1 dopamine receptor agonist SKF93 stimulates the release of glutamate in the hippocampus. Neuroscience 94. 383:1999;1063-1070.
6. Cameron D.L., Williams J.T. Dopamine D1 receptors facilitate transmitter release. Nature. 366:1993;344-347.
7. Campbell A., Villavicencio A.T., Yeghiavan S.K., Balikian R., Baldessarini R.J. Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Research. 771:1997;55-62.
8. Cartmell J., Monn J.A., Schoepp D.D. The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing. European Journal of Pharmacology. 400:2000;221-224.
9. Centonze D., Piconni B., Baunez C., Borrelli E., Pisani A., Bernadi G., Calabresi P. Cocaine and amphetamine depress striatal GABAergic synpatic transmission through D2 dopamine receptors. Neuropsychopharmacology. 26:2002;164-175.
10. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., Corsi M., Orzi F., Conquet F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neuroscience. 4:2001;873-874.
11. David H.N., Abraini J.H. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response induced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens. European Journal of Neuroscience. 13:2001;2157-2164.
12. David H.N., Abraini J.H. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens. Neuropharmacology. 41:2001;454-463.
13. David H.N., Abraini J.H. Group III metabotropic glutamate receptors and D1-like- and D2-like dopamine receptors interact in the rat nucleus accumbens to influence locomotor activity. European Journal of Neuroscience. 15:2002;869-875.
14. David H.N., Thevenoux A., Abraini J.H. Inhibition of the glutamate transporter by L-trans-PDC in the nucleus accumbens prevents the locomotor response to amphetamine. Neuropharmacology. 41:2001;409-411.
15. Del Arco A., Gonzalez-Mora J.L., Armas V.R., Mora F. Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms. Neuropharmacology. 38:1999;943-954.
16. Diaz-Cabiale Z., Vivo M., Del Arco A., O'Connor W.T., Harte M.K., Muller C.E., Martinez E., Popoli P., Fuxe K., Ferre S. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A2A and dopamine D2 receptors. Neuroscience Letters. 324:2002;154-158.
17. Dietze S., Kuschinsky K. Determination of extracelular glutamate after local K+ stimulation in the striatum of non-anaesthetised rats after treatment with dopaminergic drugs: studies using microdialysis. Journal of Neural Transmission General Section. 90:1992;1-11.
18. Essman W.D., McConigle P., Lucki I. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology. 112:1993;233-241.
19. Freed W.J. Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neuroscience and Biobehavioral Reviews. 18:1994;111-120.
20. Fritts M.E., Mueller K., Morris L. Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist. Pharmacology, Biochemistry and Behavior. 58:1997;1015-1019.
21. Gao W.J., Krimer L.S., Goldman-Rakic P.S. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proceedings of the National Academy of Sciences of the USA. 98:2001;295-300.
22. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr, Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
23. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
24. Gonzales-Islas C., Hablitz J.J. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. Journal of Neurophysiology. 86:2001;2911-2918.
25. Imperato A., Tanda G., Frau R., Di Chiara G. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. Journal of Pharmacology and Experimental Therapeutics. 245:1988;257-264.
26. Kim J.H., Vezina P. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacology, Biochemistry and Behavior. 73:2002;333-337.
27. Kim J.H., Beeler J.A., Vezina P. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology. 39:2000;1692-1699.
28. Kim J.H., Perugini M., Austin J.D., Vezina P. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited. Journal of Neuroscience. 21:2000;RC133.
29. Kim J.H., Vezina P. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Journal of Pharmacology and Experimental Therapeutics. 284:1998;317-322.
30. Kosinski C.M., Risso-Bradley S., Conn P.J., Levey A.I., Landwehrmeyer G.B., Penney J.B. Jr, Young A.B., Standaert D.G. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. Journal of Comparative Neurology. 415:1999;266-284.
31. Labarca R., Gajardo M.I., Seguel M., Silva H., Jerez S., Ruiz A., Bustos G. Effects of D-amphetamine administration on the release of endogenous excitatory amino acids in the rat nucleus accumbens. Progress in Neuropsychopharmacology and Biological Psychiatry. 19:1995;467-473.
32. Manzoni O., Michel J.M., Bockaert J. Metabotropic glutamate receptors in the rat nucleus accumbens. European Journal of Neuroscience. 9:1997;1514-1523.
33. Manzoni O.J., Weisskopf M.G., Nicoll R.A. MCPG antagonizes metabotropic glutamate receptors but not long-term potentiation in the hippocampus. European Journal of Neuroscience. 6:1994;1050-1054.
34. Mao L., Conquet F., Wang J.Q. Impaired preprodynorphin, but not preproenkephalin, mRNA induction in the striatum of mGluR1 mutant mice in response to acute administration of the full dopamine D1 agonist SKF-82958. Synapse. 44:2002;86-93.
35. Mao L., Lau Y.S., Wang J.Q. Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: and in vivo microdialysis study. European Journal of Pharmacology. 404:2000;289-297.
36. Mao L., Wang J.Q. Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats. Pharmacology, Biochemistry and Behavior. 67:2000;93-101.
37. Mao L., Wang J.Q. Protection against acute amphetamine-induced behavior by microinjection of a group II metabotropic glutamate receptor agonist into the dorsal striatum of rats. Neuroscience Letters. 270:1999;103-106.
38. Maura G., Giardi A., Raiteri M. Release-regulating D2 dopamine receptors are located on striatal glutamatergic nerve terminals. Journal of Pharmacology and Experimental Therapeutics. 247:1988;680-684.
39. Moratalla R., Xu M., Tonegawa S., Graybiel A.M. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proceedings of the National Academy of Sciences of the USA. 93:1996;14928-14933.
40. Nicola S.M., Kombian S.B., Malenka R.C. Psychostimulants depress excitatory synpatic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors. Journal of Neuroscience. 16:1996;1591-1604.
41. Neill M.F., Shaw G. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berl). 145:1999;237-250.
42. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, New York.
43. Pijnenburg A.J., Honig W.M., Van Der Heyden J.A., Van Rossum J.M. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. European Journal of Pharmacology. 35:1976;45-58.
44. Pin J.P., De Colle C., Bessis A.S., Acher F. New perspectives for the development of selective metabotropic glutamate receptor ligands. European Journal of Pharmacology. 375:1999;277-294.
45. Pisani A., Calabresi P., Centonze D., Bernadi G. Activation of group III metabotropic glutamate receptors depress glutamatergic transmission at corticostriatal synapse. Neuropharmacology. 36:1997;845-851.
46. Reid M.S., Hsu K. Jr., Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 27:1997;95-105.
47. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine effects on catecholamine systems. Annual Review of Pharmacology and Toxicology. 32:1993;639-677.
48. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. Journal of Comparative Neurology. 320:1992;145-160.
49. Sesack S.R., Pickel V.M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Research. 527:1990;266-279.
50. Siegel S., Castellan N.J. Jr. Nonparametric Statistics for the Behavioral Sciences. Statistical Series. 1988;McGraw-Hill International Editions, New York.
51. Spooren W.P., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., Porsolt R.D., Gentsch C. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. The Journal of Pharmacological Experimental Therapeutics. 295:2000;1267-1275.
52. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacology, Biochemistry and Behavior. 58:1997;933-945.
53. Swerdlow N.R., Vaccarino F.J., Amalric M., Koob G.F. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacology, Biochemistry and Behavior. 25:1986;233-248.
54. Tarazi F.I., Campbell A., Yeghiayan S.K., Baldessarini R.J. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse. 30:1998;227-235.
55. Testa C.M., Friberg I.K., Weiss S.W., Standaert D.G. Immunohistochemical localization of metabotropic gluytamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. Journal of Comparative Neurology. 390:1998;5-19.
56. Testa C.M., Standaert D.G., Young A.B., Penney J.B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. Journal of Neuroscience. 14:1994;3005-3018.
57. Wachtel S.R., Hu X.T., Galloway M.P., White F.J. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse. 4:1989;327-346.
58. Walters J.R., Bergstrom D.A., Carlson J.H., Chase T.N., Braun A.R. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science. 236:1987;719-722.
59. White F.J. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D2 receptor agonist. European Journal of Pharmacology. 135:1987;101-105.
60. Yamamoto B.K., Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. Journal of Neurochemistry. 58:1992;1736-1742.